ConductScience.org, home

Paper29970809

Present and Future Therapy of Cryptococcus Infections.

Mourad A and 1 other. J Fungi (Basel), 2018. Cited by 43 papers, by iCite.

Cite this record

ConductScience Library. Present and Future Therapy of Cryptococcus Infections. Papers, record 29970809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29970809

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Present and Future Therapy of Cryptococcus Infections.
PubMed
Journal
J Fungi (Basel)
PubMed
Year
2018
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
43
iCite
Relative citation ratio, by iCite
2.4
iCite
Revised in PubMed
2020-10-01
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mourad AAhmadhttps://orcid.org/0000-0002-3149-597X
2Perfect JRJohn R

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI073896NIAID NIH HHSUnited StatesR01AI073896PubMedNIH RePORTER
R01 AI093257NIAID NIH HHSUnited StatesR01AI093257PubMed and NIHNIH RePORTER

Download CSV of grants

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126753085Reversible Deafness and Blindness in a Patient with Cryptococcal Meningitis in Tanzania.Infect Dis Rep2015https://conductscience.org/library/papers/26753085PubMed
227664991Activity of VT-1129 against Cryptococcus neoformans clinical isolates with high fluconazole MICs.Med Mycol2017https://conductscience.org/library/papers/27664991PubMed
328783748Heat shock protein 90 localizes to the surface and augments virulence factors of Cryptococcus neoformans.PLoS Negl Trop Dis2017https://conductscience.org/library/papers/28783748PubMed
425422390Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012.Clin Infect Dis2015https://conductscience.org/library/papers/25422390PubMed
528201509In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.J Antimicrob Chemother2017https://conductscience.org/library/papers/28201509PubMed
624020737Radioimmunotherapy of Cryptococcus neoformans spares bystander mammalian cells.Future Microbiol2013https://conductscience.org/library/papers/24020737PubMed
729507066Acylhydrazones as Antifungal Agents Targeting the Synthesis of Fungal Sphingolipids.Antimicrob Agents Chemother2018https://conductscience.org/library/papers/29507066PubMed
820597693
Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings.
Clin Infect Dis2010https://conductscience.org/library/papers/20597693PubMed
915661940IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis.J Immunol2005https://conductscience.org/library/papers/15661940PubMed
101716613Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity.Infect Immun1991https://conductscience.org/library/papers/1716613PubMed
1127169478Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses.Clin Infect Dis2016https://conductscience.org/library/papers/27169478PubMed
1229190379
Fungal-specific Cyp51 inhibitor VT-1598 demonstrates in vitro activity against Candida and Cryptococcus species, endemic fungi, including Coccidioides species, Aspergillus species and Rhizopus arrhizus.
J Antimicrob Chemother2018https://conductscience.org/library/papers/29190379PubMed
1324675586Cryptococcal meningitis management in Tanzania with strict schedule of serial lumber punctures using intravenous tubing sets: an operational research study.J Acquir Immune Defic Syndr2014https://conductscience.org/library/papers/24675586PubMed
1411069257The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans.J Infect Dis2000https://conductscience.org/library/papers/11069257PubMed
1518524882Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan.Clin Vaccine Immunol2008https://conductscience.org/library/papers/18524882PubMed
1620047480Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.Clin Infect Dis2010https://conductscience.org/library/papers/20047480PubMed
1710972493Melanin and virulence in Cryptococcus neoformans.Curr Opin Microbiol2000https://conductscience.org/library/papers/10972493PubMed
181313682Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis.AIDS1992https://conductscience.org/library/papers/1313682PubMed
1929234588Emerging fluconazole resistance: Implications for the management of cryptococcal meningitis.Med Mycol Case Rep2018https://conductscience.org/library/papers/29234588PubMed
2024900384Antifungal spectrum, in vivo efficacy, and structure-activity relationship of ilicicolin h.ACS Med Chem Lett2012https://conductscience.org/library/papers/24900384PubMed

See all 54 referencesDownload CSV of references

Cited by35

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.

PMIDTitleJournalYearIn PapersSource
41595640Targeting Yeast Pathogens with Lectins: A Narrative Review from Mechanistic Insights to the Need for Addressing Translational Challenges.Biomedicines2026https://conductscience.org/library/papers/41595640PubMed
40881815Extracellular Vesicles From Fungal Infection in Humans: A Key Player in Immunological Responses.J Extracell Biol2025https://conductscience.org/library/papers/40881815PubMed
40376381Cryptococcal Meningoencephalitis With Herpes Zoster Coinfection in a Retrovirus-Positive Adolescent Male With a Normal CD4 Count: A Rare Case.Cureus2025https://conductscience.org/library/papers/40376381PubMed
39464491Cryptococcal Meningitis in an HCV-Positive and IVDU- and HIV-Negative Patient: A Case Report and Literature Review.Int Med Case Rep J2024https://conductscience.org/library/papers/39464491PubMed
39365015Fulminant Meningitis: A Rare Case of HSV-2 and Cryptococcal Co-Infection in a Patient With AIDS.J Investig Med High Impact Case Rep2024https://conductscience.org/library/papers/39365015PubMed
38324809Case report: First case of fungemia caused by Papiliotrema laurentii in a patient with SARS-CoV-2 infection.Rev Soc Bras Med Trop2024https://conductscience.org/library/papers/38324809PubMed
38305394Molecular Pathway, Epidemiological Data and Treatment Strategies of Fungal Infection (Mycoses): A Comprehensive Review.Cent Nerv Syst Agents Med Chem2024https://conductscience.org/library/papers/38305394PubMed
37998390Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species.Cells2023https://conductscience.org/library/papers/37998390PubMed
37950840Synergistic effect of the verapamil and amphotericin B against Cryptococcus neoformans.Folia Microbiol (Praha)2023https://conductscience.org/library/papers/37950840PubMed
36960287Synergistic antifungal interaction of N-(butylcarbamothioyl) benzamide and amphotericin B against Cryptococcus neoformans.Front Microbiol2023https://conductscience.org/library/papers/36960287PubMed
36815840Organoselenium Has a Potent Fungicidal Effect on Cryptococcus neoformans and Inhibits the Virulence Factors.Antimicrob Agents Chemother2023https://conductscience.org/library/papers/36815840PubMed
36748523Do mitochondria use efflux pumps to protect their ribosomes from antibiotics?Microbiology (Reading)2023https://conductscience.org/library/papers/36748523PubMed
36229573Vaccine protection by Cryptococcus neoformans Δsgl1 is mediated by γδ T cells via TLR2 signaling.Mucosal Immunol2022https://conductscience.org/library/papers/36229573PubMed
35972650Antifungal and Antibiofilm In Vitro Activities of Ursolic Acid on Cryptococcus neoformans.Curr Microbiol2022https://conductscience.org/library/papers/35972650PubMed
35615354Three Models of Vaccination Strategies Against Cryptococcosis in Immunocompromised Hosts Using Heat-Killed Cryptococcus neoformans Δsgl1.Front Immunol2022https://conductscience.org/library/papers/35615354PubMed
35472450Role of the anillin-like protein in growth of Cryptococcus neoformans at human host temperature.Fungal Genet Biol2022https://conductscience.org/library/papers/35472450PubMed
35335969Synthesis and Evaluation of the Antifungal and Toxicological Activity of Nitrofuran Derivatives.Pharmaceutics2022https://conductscience.org/library/papers/35335969PubMed
34829198Molecular Mechanisms of 5-Fluorocytosine Resistance in Yeasts and Filamentous Fungi.J Fungi (Basel)2021https://conductscience.org/library/papers/34829198PubMed
34568097Cryptococcus neoformans Δsgl1 Vaccination Requires Either CD4+ or CD8+ T Cells for Complete Host Protection.Front Cell Infect Microbiol2021https://conductscience.org/library/papers/34568097PubMed
34467755Docusate-Based Ionic Liquids of Anthelmintic Benzimidazoles Show Improved Pharmaceutical Processability, Lipid Solubility, and in Vitro Activity against Cryptococcus neoformans.ACS Infect Dis2021https://conductscience.org/library/papers/34467755PubMed

See all 35 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CALM1801PubTator's text mininghttps://conductscience.org/library/genes/801NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CXCL83576PubTator's text mininghttps://conductscience.org/library/genes/3576NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29970809

GET https://conductscience.org/api/papers/v1/29970809/references?page=2